Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $10.59 USD
Change Today +0.155 / 1.49%
Volume 2.0M
MACK On Other Exchanges
As of 3:07 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert J. Mulroy

Chief Executive Officer, President, Executive Director and Member of Executive Committee,Merrimack Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Robert J. Mulroy has been the Chief Executive Officer and President of Merrimack Pharmaceuticals, Inc. (Alternate Name: Merrimack Biopharmaceuticals, Inc.) since May 1999. Mr. Mulroy worked as a management consultant in the pharmaceutical and healthcare industries. He also worked as a consultant in the field of international development and served as an advisor to multiple start-up companies in the biotechnology industry. He served as the President and Chief Executive ...

Read Full Background

Corporate Headquarters*

One Kendall Square
Cambridge, Massachusetts 02139

United States

Phone: 617-441-1000
Fax: 617-491-1386

Board Members Memberships*

Chief Executive Officer, President, Executive Director and Member of Executive Committee


Stanford University
Master's Degree
Yale University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$527,343

Stock Options*

All Other Compensation$17,446
Exercised Options593,247
Exercised Options Value$4,022,884
Exercisable Options2,548,416
Exercisable Options Value$19,104,743
Unexercisable Options558,337
Unexercisable Options Value$2,841,768
Total Value of Options$25,969,395
Total Number of Options3,700,000

Total Compensation*

Total Annual Cash Compensation$790,099
Total Short Term Compensation$527,343
Other Long Term Compensation$17,446
Total Calculated Compensation$1,729,159
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MACK:US $10.59 USD +0.155


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERRIMACK PHARMACEUTICALS IN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at